November 18, 2016 - Metabolix, Inc. (NASDAQ:YTEN) has filed a financial statement reporting Revenue From Related Parties of $494,000 USD. Previously, on August 08, 2016, Metabolix, Inc. reported Revenue From Related Parties of $1,580,000 USD. This represents a change of -68.73% in Revenue From Related Parties.

Period EndPeriodValue
2016-09-30 2016-Q3 494,000
2016-06-30 2016-Q2 1,580,000
2016-03-31 2016-Q1 197,000
2015-09-30 2015-Q3 172,000
2015-06-30 2015-Q2 115,000
2015-03-31 2015-Q1 120,000
2014-09-30 2014-Q3 127,000
2014-06-30 2014-Q2 25,000
2014-03-31 2014-Q1 25,000
2013-09-30 2013-Q3 27,000
2013-06-30 2013-Q2 25,000
2013-03-31 2013-Q1 25,000
2012-09-30 2012-Q3 28,000
2012-06-30 2012-Q2 89,000
2012-03-31 2012-Q1 45,000
2011-09-30 2011-Q3 26,000
2011-06-30 2011-Q2 92,000
2011-03-31 2011-Q1 301,000

Other Interesting Charts

Cost Of Revenue Research And Development Expenses - Costs And Expenses - Deferred Tax Assets Capitalized Research And Development Expenses - Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost - Effective Income Tax Rate Reconciliation Nondeductible Expense - Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost - Income Tax Expense Benefit - Increase Decrease In Deferred Revenue - Increase Decrease In Prepaid Deferred Expense And Other Assets - Operating Leases Rent Expense Net - Other Nonoperating Income Expense - Prepaid Expense And Other Assets Current - Revenue From Grants - Revenue From Related Parties - Revenue Product Sales To Related Party - Revenues - Sales Revenue Net - Selling General And Administrative Expense - Stock Offering Costs Remaining In Account Payable And Accrued Expenses -

Related News Stories

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2018 Results - Earnings Call Transcript

2018-08-10 seekingalpha
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q2 2018 Results Earnings Conference Call August 9, 2018 4:30 PM ET (0-1)

Arcadia Biosciences:  A Speculative Pure-Play In The Genome Editing Agricultural Space

2018-07-16 seekingalpha
I highlight a number of reasons why I've taken a speculative position in RKDA, including commercialization prospects and cash on hand relative to historical burn rates. (5-3)

CUSIP: 591018809